New Approach Methodologies (NAMs) Archives

Guide

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…

Certara2026年5月12日

Webinar

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

Certara2026年5月8日

Blog

医薬品企業が治験薬の非動物試験へ移行するための方法

Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…

Certara2026年5月5日

Blog

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…

Certara2026年4月28日

Fact Sheet

ToxStudio® Predictive Toxicology Software

Learn about ToxStudio: Predictive toxicology software to support prediction of drug-induced liver injury (DILI), QT…

Certara2026年4月16日

Press Coverage

FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing

The FDA’s new draft guidance clarifies how drug developers can validate and use non-animal testing…

Certara2026年4月1日

Blog

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

Learn how regulatory expectations in clinical pharmacology are evolving and how to build a strategy…

Certara2026年3月24日

Blog

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…

Certara2026年2月2日

On-Demand Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…

Certara2026年1月22日

On-Demand Webinar

Safety First: 化合物スクリーニングデータに潜む臨床リスクを解明するには

Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…

Certara2026年1月13日

New Approach Methodologies (NAMs)

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

医薬品企業が治験薬の非動物試験へ移行するための方法

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

ToxStudio® Predictive Toxicology Software

FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Safety First: 化合物スクリーニングデータに潜む臨床リスクを解明するには

メルマガ登録

クイックアクセス

ソリューション

お問合せ